Studies on Phospholipids in the Action of a Lupus Coagulation Inhibitor

References

• Aberg H., Nilsson I. M. Recurrent thrombosis in a young woman with a circulating anticoagulant directed against factors XI and XII. Acta med. scand. 1972; 192: 419–425
   PubMedGoogle Scholar
• Bell W. N., Alton H. G. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature 1954; 174: 880–881
   PubMed Web of Science ®Google Scholar
• Biggs R., Denson K. W. E. The mode of action of a coagulation inhibitor in the blood of two patients with disseminated lupus erythematosus. Brit. J. Haemat. 1964; 10: 198–216
   PubMedGoogle Scholar
• Bowie E. J. W., Thompson J. H., Pascuzzi C. A., Owen C. A., Jr. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J. Lab. clin. Med. 1963; 62: 416–430
   PubMed Web of Science ®Google Scholar
• Breckenridge R. T., Ratnoff O. D. Studies on the site of action of a circulating anticoagulant in disseminated lupus erythematosus. Amer. J. Med. 1963; 35: 813–819
   PubMedGoogle Scholar
• Castro D., Farber L. R., Cline L. P. Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus. Ann. int. Med. 1972; 77: 543–548
   PubMed Web of Science ®Google Scholar
• Cole E. R., Koppel J. L., Olwin J. H. Phospholipid-protein interactions in the formation of prothrombin activator. Thrombos. Diathes. haemorrh. (Stuttg.) 1965; 14: 431–444
   PubMedGoogle Scholar
• Corrigan J. J., Jr, Patterson J. H., May N. E. Incoagulability of the blood in systemic lupus erythematosus—A case due to hypo-prothrombinemia and a circulating anticoagulant. Amer. J. Dis. Child. 1970; 119: 365–369
   Google Scholar
• Denson K. W. E. Human Blood Coagulation, R. Biggs. Blackwell Scientific Publications, Oxford 1972; 614–616
   Google Scholar
• Douglas A. S. Anticoagulant Therapy. Blackwell Scientific Publications, Oxford 1962; 271–275
   Google Scholar
• Exner T., Rickard K. A. An improved procedure for determining thromboplastin generation. J. clin. Path. 1974; 27: 683–684
   Google Scholar
• Feinstein D. I., Rapaport S. I. Acquired inhibitors of blood coagulation. Progress in Hemostasis and Thrombosis, T. N. Spaet. Grune & Stratton, New York 1972; Vol. 1: 75–95
   Google Scholar
• Folch J. Brain cephalin: A mixture of phosphatides: Separation from it of phosphatidyl serine, phosphatidyl ethanolamine and a fraction containing an inositol phosphatide. J. biol. Chem. 1942; 146: 35–41
   Google Scholar
• Gobbi F., Stefanini M. Circulating anti-AHG anticoagulant in a patient with lupus erythematosus disseminatus. Effect of a cephalin complex in vivo. Acta haemat. (Basel). 1962; 28: 155–162
   Google Scholar
• Gonyea L., Herdman R., Bridges R. A. The coagulation abnormalities in systemic lupus erythematosus. Thrombos. Diathes. haemorrh. (Stuttg.) 1968; 20: 457–464
   PubMedGoogle Scholar
• Herrmann R. P., Davey M. G., Skidmore P. H. The coagulation defect after envenoment by the bite of a Dugite (Demansis nuchalis affinis), a Western Australian brown snake. Med. J. Aust. 1972; 2: 183–186
   PubMedGoogle Scholar
• Hicks N. D., Pitney W. R. A rapid screening test for disorders of thromboplastin generation. Brit. J. Haemat. 1957; 3: 227–237
   Google Scholar
• Jones N. F., Poole-Wilson P. A. Acquired von Willebrand's syndrome and systemic lupus erythematosus. Proc. roy. Soc. Med. 1972; 65: 561–562
   Google Scholar
• Lechner K. Acquired inhibitors in non-haemophlic patients. Haemostasis. 1974; 3: 65–93
   PubMedGoogle Scholar
• Margolius A., Jr, Jackson D. P., Ratnoff O. D. Circulating anticoagulants: A study of 40 cases and a review of the literature. Medicine (Baltimore). 1961; 40: 145–202
   PubMed Web of Science ®Google Scholar
• McFarlane R. G. Russell's viper venom, 1934–64. Brit. J. Haemat. 1967; 13: 437–451
   Google Scholar
• Proctor R. R., Rapaport S. I. The partial thromboplastin time with kaolin. Am. J. clin. Path. 1961; 36: 212–219
   PubMed Web of Science ®Google Scholar
• Regan M. G., Lackner N., Karpatkin S. Platelet function and coagulation profile in lupus erythematosus. Ann. int. Med. 1974; 81: 462–468
   Google Scholar
• Sanchez-Medal L., Lisker R., Torre Lopez E. Unsusal circulating anticoagulant in a patient with systemic lupus erythematosus. Acta haemat. (Basel) 1967; 29: 117–122
   Google Scholar
• Simone J. V., Cornet J. A., Abildgaard C. F. Acquired von Willebrand's syndrome in systemic lupus erythematosus. Blood. 1968; 31: 806–812
   PubMed Web of Science ®Google Scholar
• Veltkamp J. J., Kerkhoven P., Loeliger E. A. Circulating anticoagulant in disseminated lupus erythematosus. Haemostasis. 1974; 2: 253–259
   Google Scholar
• Yin E. T., Gaston L. W. Purification and kinetic studies on a circulating and anticoagulant in a suspected case of lupus erythematosus. Thrombos. Diathes. haemorrh. (Stuttg.) 1965; 14: 88–114
   PubMedGoogle Scholar